Alignment Healthcare Shares Fall 13% After Downgrade to Contract Covering 75% of Members
Key Facts
Alignment Healthcare shares fell 13% on October 9, closing at $7.55 after touching a 52-week low, according to a report by law firm Hagens Berman carried by PR Newswire. The move followed the company’s announcement that its California health contract, H3815, would receive a 3.5-star rating for 2027, down from 4.0 stars for 2026. The contract covers about 75% of the company’s plan members, making it central to assessing the impact of the new rating. Alignment said in its filing that the 2027 ratings are not expected to affect its revenue in 2026 or 2027. But it said the change would affect quality bonus payments for fiscal 2028.
Alignment said its review of Centers for Medicare & Medicaid Services data showed the lower star performance was driven mainly by higher industry-wide cut points, along with weaker results on some triple-weighted measures in the Health Outcomes Survey and Part D measures. Cut points determine whether a contract receives one star or as many as five stars on a given measure, according to CMS. The agency had raised the weights for the measures on improving or maintaining physical health and improving or maintaining mental health from one in the 2026 ratings to three starting with the 2027 ratings. The change gives the two measures greater influence on the overall rating. The company attributed the decline to its review of CMS data, while the factors it disclosed included cut points and results on health and Part D measures.
Despite the downgrade to contract H3815, Alignment said 6 of its 7 eligible Medicare Advantage contracts received four stars or more in the 2027 ratings, including 3 contracts that earned 4.5 stars. This provides a broader picture of the company’s portfolio performance: the announced downgrade was confined to a contract covering a large share of members, while most eligible contracts remained at four stars or higher. H3815 serves about 75% of the company’s plan membership, according to its filing, underscoring the rating’s importance to its beneficiary base. In the third quarter of 2026, Alignment’s plan membership totaled about 301,200, up 31.2% year over year. Revenue rose to $1,358.3 million, up 36.7% year over year.
The company reported a net loss of $8.1 million in the third quarter of 2026, compared with net income of $3.7 million in the same period a year earlier. Adjusted EBITDA was $21.8 million, down 32.8% year over year. The figures put the contract downgrade in the context of a company that expanded membership and revenue while adjusted earnings declined and it swung to a net loss for the quarter. These results do not mean the downgrade will affect revenue in 2026 or 2027; Alignment said the expected impact concerns quality bonuses in fiscal 2028. It added that risk-sharing arrangements with care providers are expected to offset part of the impact of lower payments.
The company said it plans to file administrative appeals concerning some CMS calculations and expects to begin legal proceedings challenging certain rating measures and methodologies. It also outlined plans to expand member and care-provider engagement, address care gaps and add quality oversight. These steps come as the open enrollment period for 2027 plans was scheduled to run from October 15 through December 7, 2026, according to CMS. The agency said the 2027 ratings would appear in the Medicare Plan Finder during enrollment and would affect Medicare Advantage quality bonus payments for 2028. ALHC shares closed at $6.72 on November 18, according to EL7 data, in a session subsequent to the October 9 move tied to the ratings news.